Robotic Transversus Abdominis Release for Ventral Hernia Repair Shows Low Complications

Overview

This retrospective study evaluated short-term outcomes of robotic transversus abdominis release (TAR) with P4HB biosynthetic mesh in ventral hernia repair. Despite rising modifiable comorbidities such as obesity, diabetes, and smoking, the technique demonstrated low surgical site occurrences and short hospital stays.

Background

Ventral hernia repair is a common surgical procedure with increasing annual incidence and significant healthcare costs. Modifiable comorbidities (MCMs) like obesity, diabetes, and smoking are known to increase postoperative complications, particularly surgical site infections. Traditional studies have focused on open or laparoscopic approaches, with limited data on robotic techniques. Robotic TAR combined with advanced biomaterials such as P4HB mesh may offer improved outcomes, but the impact of MCMs on these newer methods requires further investigation.

Data Highlights

The study stratified patients by number of MCMs (0, 1, or ≥2) and BMI categories (healthy, overweight, obese, morbidly obese). All patients underwent elective robotic TAR with P4HB mesh in a clean surgical field. Follow-up was limited to 60 days postoperatively to assess short-term surgical site occurrences and hospital length of stay. Patients with contaminated procedures, emergent repairs, or incomplete records were excluded.

Key Findings

• Robotic TAR with P4HB mesh resulted in low rates of surgical site occurrences despite increasing prevalence of modifiable comorbidities.
• Patients with multiple MCMs did not demonstrate significantly higher short-term wound morbidity compared to those without MCMs.
• Hospital length of stay was short across all patient groups, indicating efficient recovery.
• The use of P4HB resorbable biosynthetic mesh as a retromuscular sublay was associated with favorable short-term outcomes.
• The robotic approach allowed precise dissection and repair, potentially mitigating risks associated with obesity, diabetes, and smoking.

Clinical Implications

Robotic TAR with P4HB mesh is a safe and effective technique for ventral hernia repair even in patients with modifiable comorbidities. Surgeons may consider this approach to reduce surgical site complications and shorten hospital stays. Optimization of patient comorbidities remains important but may be less critical in the context of this minimally invasive robotic technique.

Conclusion

Robotic transversus abdominis release combined with P4HB biosynthetic mesh demonstrates low surgical site complication rates and short hospital stays despite increasing modifiable comorbidities. This technique represents a promising advancement in ventral hernia repair.

References

1. Skoczek et al. 2022 -- Robotic TAR with P4HB Mesh Outcomes
2. CDC Guidelines -- Obesity Definition
3. VHWG Grading Scale -- Risk Stratification in Hernia Repair